RevMedica was founded on a simple belief: surgical stapling should be informed by real-time, objective data that brings greater clarity to clinical decision-making.
RevMedica's leadership team has spent decades advancing medical technology, helping bring transformative innovations from concept to commercialization worldwide.
Together, our team has contributed to hundreds of patents, successful product launches, and some of the most recognized names in surgical innovation.
By uniting our leadership team with surgeon expertise, we are challenging convention and shaping the next generation of surgical stapling.
Because building the future requires more than vision.
It requires experience.
RevMedica's growing intellectual property portfolio reflects decades of engineering expertise, clinical collaboration, and a relentless commitment to advancing the future of surgical stapling.
Issued U.S. Patents
Issued Foreign Patents
Pending Patents
FDA's Safer Technologies Program (STeP)
Through collaboration, engineering innovation, and relentless curiosity, RevMedica is building a surgical stapling future guided by greater insight, clarity, and confidence.
We never stop learning!
The future of surgical stapling will be shaped by surgeons, innovators, researchers, and partners committed to expanding what is possible through deeper understanding.
Join us as we continue exploring what's next.
